204 related articles for article (PubMed ID: 15274754)
1. Influence of polymerization technique and experimental variables on the particle properties and release kinetics of methotrexate from poly(butylcyanoacrylate) nanoparticles.
Reddy LH; Murthy RR
Acta Pharm; 2004 Jun; 54(2):103-18. PubMed ID: 15274754
[TBL] [Abstract][Full Text] [Related]
2. Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: Physicochemical characterization and stability study.
Mulik R; Mahadik K; Paradkar A
Eur J Pharm Sci; 2009 Jun; 37(3-4):395-404. PubMed ID: 19491031
[TBL] [Abstract][Full Text] [Related]
3. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
Gao K; Jiang X
Int J Pharm; 2006 Mar; 310(1-2):213-9. PubMed ID: 16426779
[TBL] [Abstract][Full Text] [Related]
4. Study of carbonyl iron/poly(butylcyanoacrylate) (core/shell) particles as anticancer drug delivery systems Loading and release properties.
Arias JL; Linares-Molinero F; Gallardo V; Delgado AV
Eur J Pharm Sci; 2008 Mar; 33(3):252-61. PubMed ID: 18249100
[TBL] [Abstract][Full Text] [Related]
5. Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems.
Mitra A; Lin S
J Pharm Pharmacol; 2003 Jul; 55(7):895-902. PubMed ID: 12906746
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of polyacrylonitrile nanoparticles by dispersion/emulsion polymerization process.
Boguslavsky L; Baruch S; Margel S
J Colloid Interface Sci; 2005 Sep; 289(1):71-85. PubMed ID: 16009219
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
Liu J; Gong T; Wang C; Zhong Z; Zhang Z
Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and in vitro 5-Fu release behavior of poly(2,2-dimethyltrimethylene carbonate)-poly(ethylene glycol)-poly(2,2-dimethyltrimethylene carbonate) nanoparticles.
Zhang Y; Zhuo RX
J Biomed Mater Res A; 2006 Mar; 76(4):674-80. PubMed ID: 16302226
[TBL] [Abstract][Full Text] [Related]
9. ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Mol Pharm; 2010 Jun; 7(3):815-25. PubMed ID: 20230014
[TBL] [Abstract][Full Text] [Related]
10. Poly(alkylcyanoacrylate) colloidal particles as vehicles for antitumour drug delivery: a comparative study.
Arias JL; Ruiz MA; López-Viota M; Delgado AV
Colloids Surf B Biointerfaces; 2008 Mar; 62(1):64-70. PubMed ID: 17961994
[TBL] [Abstract][Full Text] [Related]
11. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
Jin X; Huang A; Ping Q; Cao F; Su Z
Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and drug release behavior of poly (trimethylene carbonate)-poly (ethylene glycol)-poly (trimethylene carbonate) nanoparticles.
Zhang Y; Zhuo RX
Biomaterials; 2005 May; 26(14):2089-94. PubMed ID: 15576183
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopy.
Weyermann J; Lochmann D; Georgens C; Rais I; Kreuter J; Karas M; Wolkenhauer M; Zimmer A
Eur J Pharm Biopharm; 2004 Jul; 58(1):25-35. PubMed ID: 15207534
[TBL] [Abstract][Full Text] [Related]
14. Miniemulsion polymerizations of n-butyl cyanoacrylate via two routes: towards a control of particle degradation.
Hansali F; Poisson G; Wu M; Bendedouch D; Marie E
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):332-8. PubMed ID: 21802908
[TBL] [Abstract][Full Text] [Related]
15. The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles.
Dillen K; Weyenberg W; Vandervoort J; Ludwig A
Eur J Pharm Biopharm; 2004 Nov; 58(3):539-49. PubMed ID: 15451528
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
Derakhshandeh K; Erfan M; Dadashzadeh S
Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
[TBL] [Abstract][Full Text] [Related]
17. Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: optimisation and in vivo evaluation.
Graf A; Rades T; Hook SM
Eur J Pharm Sci; 2009 Apr; 37(1):53-61. PubMed ID: 19167488
[TBL] [Abstract][Full Text] [Related]
18. Microporous structure and drug release kinetics of polymeric nanoparticles.
Sant S; Thommes M; Hildgen P
Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222
[TBL] [Abstract][Full Text] [Related]
19. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
Bozdag S; Dillen K; Vandervoort J; Ludwig A
J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924
[TBL] [Abstract][Full Text] [Related]
20. Increasing entrapment of peptides within poly(alkyl cyanoacrylate) nanoparticles prepared from water-in-oil microemulsions by copolymerization.
Liang M; Davies NM; Toth I
Int J Pharm; 2008 Oct; 362(1-2):141-6. PubMed ID: 18598746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
